The U.S. Food and Drug Administration has approved the expanded use of Johnson & Johnson's drug Caplyta as an add-on treatment for adults with major depressive disorder, the company said on Thursday.
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Study Overview: Pfizer Inc. is conducting a Phase 1 clinical study titled ...
Europe’s medicines regulator has issued guidance limiting the use of Tegretol (carbamazepine) 100 mg/5 mL oral suspension in neonates due to propylene glycol concentrations that exceed recommended ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback